Quitting Matters Human Immunodeficiency Virus Hybrid Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Quitting Matters Human Immunodeficiency Virus Hybrid Trial — Stella

Recruiting

Back to Tobacco trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Wake Forest University, Implementation Science, Winston-Salem, North Carolina

Key details

Sponsor

Wake Forest University Health Sciences

Collaborators

University at Buffalo, National Institutes of Health (NIH)

Enrollment target

~314 participants

Started

August 2025

Primary completion

December 2028

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov